Free tool
FAERS Monitor: Abilify Maintena Kit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 202971 or its brand name (Abilify Maintena Kit, Aripiprazole). Reports on generic versions are filed under their own applications.
Reports
50,729
Serious
40,598
80% of reports
Hospitalization
18,991
Death reported
3,761
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,990
- off label use3,660
- product use in unapproved indication3,098
- weight increased2,709
- drug interaction2,504
- anxiety2,166
- condition aggravated1,873
- fatigue1,818
- suicide attempt1,716
- suicidal ideation1,660
- psychotic disorder1,642
- nausea1,627
- somnolence1,592
- schizophrenia1,588
- akathisia1,496
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 68 |
| 2005 | 111 |
| 2006 | 161 |
| 2007 | 217 |
| 2008 | 192 |
| 2009 | 256 |
| 2010 | 342 |
| 2011 | 354 |
| 2012 | 534 |
| 2013 | 487 |
| 2014 | 945 |
| 2015 | 2,167 |
| 2016 | 2,091 |
| 2017 | 3,545 |
| 2018 | 3,905 |
| 2019 | 3,887 |
| 2020 | 3,923 |
| 2021 | 5,155 |
| 2022 | 4,387 |
| 2023 | 4,862 |
| 2024 | 4,971 |
| 2025 | 4,466 |
| 2026 | 3,703 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,430 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| schizophreniaSignal | 1,588 | 62.2 | 59.0 | 83,096 |
| akathisiaSignal | 1,496 | 50.9 | 48.3 | 65,198 |
| psychotic disorderSignal | 1,642 | 24.4 | 23.2 | 34,759 |
| suicide attemptSignal | 1,716 | 12.0 | 11.5 | 16,928 |
| suicidal ideationSignal | 1,660 | 7.6 | 7.3 | 9,439 |
| drug interactionSignal | 2,504 | 6.6 | 6.4 | 11,874 |
| product use in unapproved indicationSignal | 3,098 | 5.2 | 5.1 | 10,604 |
| weight increasedSignal | 2,709 | 5.1 | 4.9 | 8,820 |
| somnolenceSignal | 1,592 | 3.3 | 3.1 | 2,549 |
| anxietySignal | 2,166 | 3.2 | 3.0 | 3,239 |
| condition aggravatedSignal | 1,873 | 2.6 | 2.5 | 1,800 |
| off label use | 3,660 | 1.7 | 1.7 | 1,186 |
| drug ineffective | 4,990 | 1.6 | 1.5 | 1,103 |
| fatigue | 1,818 | 1.0 | 0.9 | 2 |
| nausea | 1,627 | 0.9 | 0.8 | 43 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.